A Comprehensive Review of Tuberculosis: Epidemiology, Diagnosis, Treatment, Prevention, and Research
DOI:
https://doi.org/10.32628/IJSRSET2512405Keywords:
Tuberculosis, MDR-TB, Diagnosis, Host-Directed Therapies, Epidemiology, BCG Vaccine, Drug ResistanceAbstract
Tuberculosis (TB), which is triggered by Mycobacterium tuberculosis, continues to be a prominent contributor to infectious disease-related deaths worldwide, even after many years of attempts to manage it. Exceeding 10 million instances and surpassing a million fatalities each year, tuberculosis predominantly impacts nations with low to middle income. This is fuelled by elements like poverty, dense living conditions, inadequate nutrition, and co-infection with HIV. The rise of multidrug-resistant and extensively drug-resistant tuberculosis has added complexity to control measures. This evaluation delves into the comprehensive range of tuberculosis—covering aspects such as transmission, pathogenesis, worldwide epidemiology, diagnostic methods, treatment protocols, drug resistance, preventive measures, and current research endeavours. Focus is directed towards innovative molecular diagnostics, the incorporation of artificial intelligence, therapies aimed at the host, and the relationship between tuberculosis and comorbid conditions such as HIV and diabetes. An approach that encompasses multiple sectors and is fuelled by innovation is essential for achieving worldwide tuberculosis elimination goals.
📊 Article Downloads
References
World Health Organization. Global Tuberculosis Report 2023. https://www.who.int/publications/i/item/9789240076729
Esmail, H., et al. (2018). Nature Reviews Disease Primers, 4(1):27. DOI: https://doi.org/10.1038/s41572-018-0024-5
Flynn, J. L., & Chan, J. (2001). Nature Reviews Microbiology, 2(7), 568–578.
Boehme, C. C., et al. (2010). Expert Review of Molecular Diagnostics, 10(9), 987–993. DOI: https://doi.org/10.1586/erm.10.85
Conradie, F., et al. (2022). Lancet Respiratory Medicine, 10(2), 144–155. DOI: https://doi.org/10.1016/S2213-2600(22)00018-2
Zumla, A., et al. (2015). The Lancet Infectious Diseases, 15(4), 414–426. DOI: https://doi.org/10.1016/S1473-3099(15)00324-2
Fox, G. J., et al. (2013). IJTLD, 17(6), 603–612. DOI: https://doi.org/10.1080/17550912.2013.835996
Schrager, L. K., et al. (2020). Nature Reviews Immunology, 20(9), 555–562.
World Health Organization. (2021). Global tuberculosis report 2021. World Health Organization. https://www.who.int/teams/global-tuberculosis-programme/tb-reports
Lawn, S. D., & Zumla, A. I. (2011). Tuberculosis. The Lancet, 378(9785), 57–72. https://doi.org/10.1016/S0140-6736(10)62173-3 DOI: https://doi.org/10.1016/S0140-6736(10)62173-3
World Health Organization. (2021). Tuberculosis: Key facts. https://www.who.int/news-room/fact-sheets/detail/tuberculosis
Esmail, H., Barry III, C. E., Young, D. B., & Wilkinson, R. J. (2018). The ongoing challenge of latent tuberculosis. The New England Journal of Medicine, 379(14), 1356–1366. https://doi.org/10.1056/NEJMra1800837
Dheda, K., Barry III, C. E., & Maartens, G. (2019). The epidemiology of tuberculosis: A global perspective. Clinics in Chest Medicine, 40(4), 653–677. https://doi.org/10.1016/j.ccm.2019.08.001 DOI: https://doi.org/10.1016/j.ccm.2019.08.001
Pai, M., Schito, M., Migliori, G. B., & Loddenkemper, R. (2017). Tuberculosis diagnostics: Challenges and opportunities. Microbiology Spectrum, 5(1), TNMI7-0030-2016. https://doi.org/10.1128/microbiolspec.TNMI7-0030-2016
Nahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., ... & Menzies, D. (2016). Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: Treatment of drug-susceptible tuberculosis. Clinical Infectious Diseases, 63(7), e147–e195. https://doi.org/10.1093/cid/ciw376 DOI: https://doi.org/10.1093/cid/ciw376
Udwadia, Z. F., Amale, R. A., Ajbani, K. K., & Rodrigues, C. (2012). Multidrug-resistant tuberculosis in India: Problems and solutions. The Lancet Infectious Diseases, 12(1), 28–35. https://doi.org/10.1016/S1473-3099(11)70374-5
Gygli, S. M., Borrell, S., Trauner, A., & Gagneux, S. (2017). Antimicrobial resistance in Mycobacterium tuberculosis: Mechanistic and evolutionary perspectives. Clinical Microbiology Reviews, 30(4), 887–920. https://doi.org/10.1128/CMR.00057-16
Lange, C., Dheda, K., Chesov, D., Mandalakas, A. M., Udwadia, Z., & Horsburgh, C. R. (2018). Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. Journal of Internal Medicine, 284(2), 163–188. https://doi.org/10.1111/joim.12740 DOI: https://doi.org/10.1111/joim.12740
Nahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., ... & Menzies, D. (2016). Executive summary: Official ATS/CDC/IDSA clinical practice guidelines: Treatment of drug-susceptible tuberculosis. Clinical Infectious Diseases, 63(7), 853–867. https://doi.org/10.1093/cid/ciw566 DOI: https://doi.org/10.1093/cid/ciw566
Zhang, Y., & Yew, W. W. (2015). Mechanisms of drug resistance in Mycobacterium tuberculosis. The International Journal of Tuberculosis and Lung Disease, 19(11), 1276–1287. https://doi.org/10.5588/ijtld.15.0389 DOI: https://doi.org/10.5588/ijtld.15.0389
Furin, J., Cox, H., & Pai, M. (2019). Tuberculosis. The Lancet, 393(10181), 1642–1656. https://doi.org/10.1016/S0140-6736(19)30308-3 DOI: https://doi.org/10.1016/S0140-6736(19)30308-3
McShane, H. (2015). Tuberculosis vaccines: Beyond BCG. Philosophical Transactions of the Royal Society B: Biological Sciences, 370(1671), 20140306. https://doi.org/10.1098/rstb.2014.0306 DOI: https://doi.org/10.1098/rstb.2014.0306
Lönnroth, K., Migliori, G. B., Abubakar, I., D'Ambrosio, L., De Vries, G., Diel, R., ... & Raviglione, M. (2015). Towards tuberculosis elimination: An action framework for low-incidence countries. European Respiratory Journal, 45(4), 928–952. https://doi.org/10.1183/09031936.00214014 DOI: https://doi.org/10.1183/09031936.00214014
Alemu, A., Bitew, Z. W., Diriba, G., & Gumi, B. (2021). Co-occurrence of tuberculosis and diabetes mellitus, and associated risk factors in Ethiopia: A systematic review and meta-analysis. IJID Regions, 1, 82–91. https://doi.org/10.1016/j.ijregi.2021.10.004 DOI: https://doi.org/10.1016/j.ijregi.2021.10.004
World Health Organization. (2021). Global tuberculosis report 2021. https://www.who.int/publications-detail-redirect/9789240037021
Joint United Nations Programme on HIV/AIDS (UNAIDS). (2020). UNAIDS data 2020. https://www.unaids.org/en/resources/documents/2020/unaids-data
American Diabetes Association Professional Practice Committee. (2022). 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2022. Diabetes Care, 45(Suppl 1), S17–S38. https://doi.org/10.2337/dc22-S002 DOI: https://doi.org/10.2337/dc22-S002
Centers for Disease Control and Prevention. (2021). Tuberculosis and HIV coinfection. https://www.cdc.gov/tb/topic/basics/tbhivcoinfection.htm
Falzon, D., Schünemann, H. J., Harausz, E., et al. (2017). World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. European Respiratory Journal, 49(3), 1602308. https://doi.org/10.1183/13993003.02308-2016 DOI: https://doi.org/10.1183/13993003.02308-2016
Yorke, E., Atiase, Y., Akpalu, J., Sarfo-Kantanka, O., Boima, V., & Dey, I. D. (2017). The bidirectional relationship between tuberculosis and diabetes. Tuberculosis Research and Treatment, 2017, 1702578. https://doi.org/10.1155/2017/1702578 DOI: https://doi.org/10.1155/2017/1702578
Zeru, M. A. (2021). Prevalence and associated factors of HIV-TB co-infection among HIV patients: A retrospective study. African Health Sciences, 21(3), 1003–1009. https://doi.org/10.4314/ahs.v21i3.79 DOI: https://doi.org/10.4314/ahs.v21i3.7
World Health Organization. (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. https://pubmed.ncbi.nlm.nih.gov/24716260/
Bruchfeld, J., Correia-Neves, M., & Källenius, G. (2015). Tuberculosis and HIV coinfection. Cold Spring Harbor Perspectives in Medicine, 5(7), a017871. https://doi.org/10.1101/cshperspect.a017871 DOI: https://doi.org/10.1101/cshperspect.a017871
Alebel, A., Wondemagegn, A. T., Tesema, C., Kibret, G. D., Wagnew, F., Petrucka, P., Arora, A., Ayele, A. D., Alemayehu, M., & Eshetie, S. (2019). Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: A systematic review and meta-analysis of observational studies. BMC Infectious Diseases, 19(1), 254. https://doi.org/10.1186/s12879-019-3892-8 DOI: https://doi.org/10.1186/s12879-019-3892-8
Gelaw, Y. A., Williams, G., Soares Magalhães, R. J., Gilks, C. F., & Assefa, Y. (2019). HIV prevalence among tuberculosis patients in Sub-Saharan Africa: A systematic review and meta-analysis. AIDS and Behavior, 23(6), 1561–1575. https://doi.org/10.1007/s10461-018-02386-4
Ngari, M. M., Rashid, M. A., Sanga, D., Mathenge, H., Agoro, O., Mberia, J. K., Katana, G. G., Vaillant, M., & Abdullahi, O. A. (2023). Burden of HIV and treatment outcomes among TB patients in rural Kenya: A 9-year longitudinal study. BMC Infectious Diseases, 23(1), 362. https://doi.org/10.1186/s12879-023-08347-0 DOI: https://doi.org/10.1186/s12879-023-08347-0
Chakaya, J. M., Harries, A. D., & Marks, G. B. (2020). Ending tuberculosis by 2030—Pipe dream or reality? International Journal of Infectious Diseases, 92S, S51–S54. https://doi.org/10.1016/j.ijid.2020.02.021 DOI: https://doi.org/10.1016/j.ijid.2020.02.021
United Nations General Assembly. (2018). Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis: Resolution adopted by the General Assembly (73rd sess.). https://digitallibrary.un.org/record/1649568
Enos, M., Sitienei, J., Ong'ang'o, J., Mungai, B., Kamene, M., Wambugu, J., Kipruto, H., Manduku, V., Mburu, J., & Nyaboke, D., et al. (2018). Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya. PLOS ONE, 13(12), e0209098. https://doi.org/10.1371/journal.pone.0209098 DOI: https://doi.org/10.1371/journal.pone.0209098
Straetemans, M., Bierrenbach, A. L., Nagelkerke, N., Glaziou, P., & van der Werf, M. J. (2010). The effect of tuberculosis on mortality in HIV positive people: A meta-analysis. PLOS ONE, 5(12), e15241. https://doi.org/10.1371/journal.pone.0015241 DOI: https://doi.org/10.1371/journal.pone.0015241
Gao, J., Zheng, P., & Fu, H. (2013). Prevalence of TB/HIV co-infection in countries except China: A systematic review and meta-analysis. PLOS ONE, 8(5), e64915. https://doi.org/10.1371/journal.pone.0064915 DOI: https://doi.org/10.1371/journal.pone.0064915
Gelaw, Y. A., Williams, G., Soares Magalhães, R. J., Gilks, C. F., & Assefa, Y. (2019). HIV prevalence among tuberculosis patients in Sub-Saharan Africa: A systematic review and meta-analysis. AIDS and Behavior, 23(6), 1561–1575. https://doi.org/10.1007/s10461-018-02386-4 DOI: https://doi.org/10.1007/s10461-018-02386-4
Endalamaw, A., Ambachew, S., Geremew, D., & Habtewold, T. D. (2019). HIV infection and unknown HIV status among tuberculosis patients in Ethiopia: A systematic review and meta-analysis. International Journal of Tuberculosis and Lung Disease, 23(2), 187–194. https://doi.org/10.5588/ijtld.18.0363 DOI: https://doi.org/10.5588/ijtld.18.0363
McHunu, G., van Griensven, J., Hinderaker, S. G., Kizito, W., Sikhondze, W., Manzi, M., Dlamini, T., & Harries, A. D. (2016). High mortality in tuberculosis patients despite HIV interventions in Swaziland. Public Health Action, 6(2), 105–110. https://doi.org/10.5588/pha.15.0081 DOI: https://doi.org/10.5588/pha.15.0081
Masini, E. O., Mansour, O., Speer, C. E., Addona, V., Hanson, C. L., Sitienei, J. K., Kipruto, H. K., Githiomi, M. M., & Mungai, B. N. (2016). Using survival analysis to identify risk factors for treatment interruption among new and retreatment tuberculosis patients in Kenya. PLOS ONE, 11(10), e0164172. https://doi.org/10.1371/journal.pone.0164172 DOI: https://doi.org/10.1371/journal.pone.0164172
Al-Karawi, A. S., Kadhim, A. A., & Kadum, M. M. (2023). Recent advances in tuberculosis: A comprehensive review of emerging trends in pathogenesis, diagnostics, treatment, and prevention. International Journal of Clinical Biochemistry and Research, 10(4), 262-269. DOI: https://doi.org/10.18231/j.ijcbr.2023.048
Usmonov, I. X., & Kobilov, N. Y. (2021). Epidemiology, Clinical Course, Diagnosis and Treatment of Generalized Tuberculosis in Modern Circumstances. Literature Review. Annals of the Romanian Society for Cell Biology, 25(2), 3806-3819.
Okram, M., & Singh, O. M. (2024). Tuberculosis: A narrative review on epidemiology, risks, implications, preventions and treatments. Int. J. Res. Med. Sci, 12(6), 2172. DOI: https://doi.org/10.18203/2320-6012.ijrms20241585
Gopalaswamy, R., Shanmugam, S., Mondal, R., & Subbian, S. (2020). Of tuberculosis and non-tuberculous mycobacterial infections–a comparative analysis of epidemiology, diagnosis and treatment. Journal of biomedical science, 27(1), 74. DOI: https://doi.org/10.1186/s12929-020-00667-6
Floyd, K., Glaziou, P., Zumla, A., & Raviglione, M. (2018). The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. The Lancet Respiratory Medicine, 6(4), 299-314. DOI: https://doi.org/10.1016/S2213-2600(18)30057-2
Qureshi, K. A., Parvez, A., Fahmy, N. A., Abdel Hady, B. H., Kumar, S., Ganguly, A., ... & Aspatwar, A. (2023). Brucellosis: epidemiology, pathogenesis, diagnosis and treatment–a comprehensive review. Annals of medicine, 55(2), 2295398. DOI: https://doi.org/10.1080/07853890.2023.2295398
Arslan, M., Arshad, R., Hameed, F., Iqbal, S., Ahmad, I., Mubeen, A., & Khan, I. U. D. (2025). A Comprehensive Review of Drug-Resistant Tuberculosis: Mechanisms, Epidemiology, and Diagnostic Approaches. Insights-Journal of Health and Rehabilitation, 3(2 (Health & Allied)), 295-302. DOI: https://doi.org/10.71000/n06wvf68
Bergman, A., & Thomas, T. (2024). Overview of the epidemiology, diagnosis, and clinical care considerations for people living with and at risk for tuberculosis in the United States. Nursing Clinics. DOI: https://doi.org/10.1016/j.cnur.2024.10.004
Sharma, S. K., & Upadhyay, V. (2020). Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian Journal of Medical Research, 152(3), 185-226. DOI: https://doi.org/10.4103/ijmr.IJMR_902_20
Kaur, J., Deshmukh, P. T., Gaurkar, S. S., & Deshmukh, P. (2024). Otorhinolaryngologic Manifestations of Tuberculosis: A Comprehensive Review of Clinical and Diagnostic Challenges. Cureus, 16(7). DOI: https://doi.org/10.7759/cureus.64586
Sgaragli, G., & Frosini, M. (2016). Human tuberculosis I. Epidemiology, diagnosis and pathogenetic mechanisms. Current medicinal chemistry, 23(25), 2836-2873. DOI: https://doi.org/10.2174/0929867323666160607222854
Chatterjee, D., & Pramanik, A. K. (2015). Tuberculosis in the African continent: A comprehensive review. Pathophysiology, 22(1), 73-83. DOI: https://doi.org/10.1016/j.pathophys.2014.12.005
Tiberi, S., Utjesanovic, N., Galvin, J., Centis, R., D'Ambrosio, L., van den Boom, M., ... & Migliori, G. B. (2022). Drug resistant TB–latest developments in epidemiology, diagnostics and management. International Journal of Infectious Diseases, 124, S20-S25. DOI: https://doi.org/10.1016/j.ijid.2022.03.026
Sheikhpour, M., Mirbahari, S. N., Sadr, M., Maleki, M., Arabi, M., & Abolfathi, H. (2023). A comprehensive study on the correlation of treatment, diagnosis and epidemiology of tuberculosis and lung cancer. Tanaffos, 22(1), 7.
Seddon, J. A., Tugume, L., Solomons, R., Prasad, K., Bahr, N. C., & Tuberculous Meningitis International Research Consortium. (2019). The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes. Wellcome open research, 4, 167. DOI: https://doi.org/10.12688/wellcomeopenres.15535.1
Pitchenik, A. E., Fertel, D., & Bloch, A. B. (1988). Mycobacterial disease: epidemiology, diagnosis, treatment, and prevention. Clinics in chest medicine, 9(3), 425-441. DOI: https://doi.org/10.1016/S0272-5231(21)00520-7
Shingadia, D. V., & Baumer, J. H. (2007). Tuberculosis: diagnosis, management and prevention. Archives of Disease in Childhood-Education and Practice, 92(1), ep27-ep29. DOI: https://doi.org/10.1136/adc.2006.110577
Cleveland, J. L., Robison, V. A., & Panlilio, A. L. (2009). Tuberculosis epidemiology, diagnosis and infection control recommendations for dental settings: an update on the Centers for Disease Control and Prevention guidelines. The Journal of the American Dental Association, 140(9), 1092-1099. DOI: https://doi.org/10.14219/jada.archive.2009.0335
Yadav, S., & Rawal, G. (2024). Understanding the spectrum and management of post-tuberculosis lung disease: a comprehensive review. Cureus, 16(6). DOI: https://doi.org/10.7759/cureus.63420
Davidson, G., Davidson, D. U., Okoye, O. K., Mensah, L. S., Ukaegbu, E. C., Agbor, D. B. A., ... & Uche, C. J. (2024). Overview of tuberculosis: causes, symptoms and risk factors. Asian J Res Infect Dis, 15(9), 8-19. DOI: https://doi.org/10.9734/ajrid/2024/v15i9370
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Scientific Research in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
